Table of Contents
Table of Contents
Words of Wisdom
About this Book
About the Author
PART I. Introduction
Chapter 1. Alcohol Addiction (Basic Background)
Chapter 2. Global Incidence of Fetal Alcohol Syndrome
Chapter 3. FASD and Loss of Economy and Productivity
Chapter 4. Fetal Alcohol Spectrum Disorder (Historical Perspective and Clinical Symptoms)
Chapter 5. FASD and Other Mental Health Disorders
Part II. Molecular Mechanisms of FASD
Chapter 6. Molecular Mechanisms of FASD
Chapter 7. Conventional and Potential FASD Biomarkers
Chapter 8. Pharmacogenomics of FASD
Chapter 9. Epigenetics of FASD (Part-1)
Chapter 10. Epigenetics of FASD (Part-2)
Chapter 11. Microarray Analyses of FASD
Part III. Basic Concepts of FASD
Chapter 12. Clinical Significance of Charnoly Body (CB) in FASD
Chapter 13. CB Pathogenesis of FASD (A Compromised Charnolophagy in FASD)
Chapter 14. Mitochondrial Bioenergetics of FASD (Recent Update)
Chapter 15. Clinical Significance of Charnolophagy in FASD
Chapter 16. Micro-RNA and FASD
Chapter 17. Clinical Benefits of Animal Models in FASD
Part IV. Recent Experimental Studies on FASD
Chapter 18. In-Vitro Experimental Models of FASD
Chapter 19. Emerging Cellular and Molecular Mechanisms of FASD
Chapter 20. Cerebral Organoids and Cell Culture Studies of FASD
Chapter 21. Emerging Molecular Mechanisms of Neurotoxicity of FASD
Chapter 22. FASD: Recent Update
Part V. FASD Neuroprotection and Treatment
Chapter 23. Molecular Mechanisms of Neuroprotection in FASD
Chapter 24. Fetal Alcohol Spectrum Disorder (FASD) Prevention, Diagnosis, and Treatment
Chapter 25. Prevention and Treatment of FASD (Recent Update)
This book provides basic and applied knowledge about FASD, its basic molecular mechanism of occurrence during prezygotic and postzygotic phase due to Ethanol-induced diversified charnolopathies. Basic knowledge of emerging charnolopharmacotherapeutics is provided for the safe and effective clinical management of FASD. The book will be valuable source of new knowledge for doctors, patients, medical students, teachers, researchers, and basic biomedical scientists.
The book will be highly useful for general public interested in learning more about FASD without any misconception and/or misunderstanding for its prevention and/or treatment to prevent chronic diseases, early morbidity, and mortality.
Neonatologists, Pediatricians, Neurologist, and Neuropsychiatrists will find this book interesting for the effective clinical management of FASD victims. The book will be of immediate interest to FASD parents and FASD victims to alleviate their sufferings.
Physicians interested in prescribing and learning more about FASD and their molecular and pharmacological mechanism(s) of neuroprotection will find this book high beneficial. They will be highly benefited from its informative and basic and clinically-interesting contents.
In general, the book will be a valuable source of knowledge for the basic researcher, clinically useful for the physician, and therapeutically-beneficial for FASD patients and their families.
In addition to physicians, the book can be a valuable for Masters and Ph. D students interested in conducting further research on FASD for the effective clinical management of various associated neurological and psychiatric disorders like ADHD in these patients.
Particularly, MD doctors, students, and professors will find this book interesting and informative to enhance their basic existing knowledge about FASD and its prevention and/or treatment for a better quality of life.